Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1096458
Reference50 articles.
1. Adoptive cell transfer: a clinical path to effective cancer immunotherapy
2. At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
3. MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
4. Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin
5. Down-Regulation of HLA Class I Antigen Processing Molecules: An Immune Escape Mechanism of Renal Cell Carcinoma?
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chimeric antigen receptor engineered natural killer cells for cancer therapy;Experimental Hematology & Oncology;2023-08-10
2. Cancer immunotherapy via stem cell-derived NK cells;Immunotherapy;2023-08
3. Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells;iScience;2023-07
4. Current Understanding of Flavonoids in Cancer Therapy and Prevention;Metabolites;2023-03-27
5. Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B;International Journal of Molecular Sciences;2023-02-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3